Product ID: SQMIG35H2167
Report ID:
SQMIG35H2167 |
Region:
Global |
Published Date: February, 2024
Pages:
165
|
Tables:
70 |
Figures:
75
Companies in the global biosimilar market could contribute money to mergers and acquisitions, product launches, changes in technology, and R&D projects. Major corporations may also spend money on new product development and marketing in the next few years. The market's greatest share belonged to Amgen Inc. It created a market for the breakthrough medicine "Mvasi," and the increased countrywide prescription rate is the primary driver of the firm's supremacy in 2021.
Biosimilars Market Top Players Company Profiles
Biosimilars Market Recent Development
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONBiosimilars Market size was valued at USD 15.6 billion in 2019 and is poised to grow from USD 19.27 billion in 2023 to USD 128.76 billion by 2031, growing at a CAGR of 23.5% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35H2167